ES2039177B1 - Proceso de preparacion de compuestos farmaceuticos solidos que contienen un ingrediente activo sensible a la luz - Google Patents
Proceso de preparacion de compuestos farmaceuticos solidos que contienen un ingrediente activo sensible a la luzInfo
- Publication number
- ES2039177B1 ES2039177B1 ES9101701A ES9101701A ES2039177B1 ES 2039177 B1 ES2039177 B1 ES 2039177B1 ES 9101701 A ES9101701 A ES 9101701A ES 9101701 A ES9101701 A ES 9101701A ES 2039177 B1 ES2039177 B1 ES 2039177B1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- active ingredient
- solid pharmaceutical
- pharmaceutical compounds
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000004480 active ingredient Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 3
- 239000002775 capsule Substances 0.000 abstract 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 abstract 2
- 229960001597 nifedipine Drugs 0.000 abstract 2
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 239000012752 auxiliary agent Substances 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU904564A HUT59592A (en) | 1990-07-20 | 1990-07-20 | Process for the preparation of solid medical products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2039177A1 ES2039177A1 (es) | 1993-09-01 |
| ES2039177B1 true ES2039177B1 (es) | 1994-03-16 |
Family
ID=10968329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES9101701A Expired - Fee Related ES2039177B1 (es) | 1990-07-20 | 1991-07-19 | Proceso de preparacion de compuestos farmaceuticos solidos que contienen un ingrediente activo sensible a la luz |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPH04253924A (en:Method) |
| KR (1) | KR920002162A (en:Method) |
| BE (1) | BE1006829A3 (en:Method) |
| CA (1) | CA2047482A1 (en:Method) |
| CH (1) | CH681960A5 (en:Method) |
| CY (1) | CY1840A (en:Method) |
| CZ (1) | CZ280064B6 (en:Method) |
| DE (1) | DE4124081A1 (en:Method) |
| DK (1) | DK137591A (en:Method) |
| ES (1) | ES2039177B1 (en:Method) |
| FI (1) | FI913493L (en:Method) |
| FR (1) | FR2664814B1 (en:Method) |
| GB (1) | GB2246072B (en:Method) |
| GR (1) | GR1002175B (en:Method) |
| HU (1) | HUT59592A (en:Method) |
| IL (1) | IL98894A0 (en:Method) |
| IT (1) | IT1250681B (en:Method) |
| NL (1) | NL9101268A (en:Method) |
| SE (1) | SE9102160L (en:Method) |
| TW (1) | TW203012B (en:Method) |
| YU (1) | YU47573B (en:Method) |
| ZA (1) | ZA915677B (en:Method) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9411115D0 (en) * | 1994-06-03 | 1994-07-27 | Secr Defence | Stabilisation of photosensitive material |
| RU2109510C1 (ru) * | 1995-04-24 | 1998-04-27 | Пфайзер Инк. | Способ ингибирования, таблетка и капсула |
| DE19912623A1 (de) * | 1999-03-20 | 2000-09-28 | Lohmann Therapie Syst Lts | Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile |
| JP3549522B1 (ja) * | 2003-10-24 | 2004-08-04 | 日清ファルマ株式会社 | コエンザイムｑ１０含有カプセル剤 |
| WO2010038771A1 (ja) * | 2008-09-30 | 2010-04-08 | 中外製薬株式会社 | 光安定化された医薬組成物 |
| CA2968861C (en) | 2017-05-30 | 2022-10-11 | University Of Saskatchewan | Topical nifedipine formulations and uses thereof |
| KR200489660Y1 (ko) * | 2018-02-09 | 2019-07-19 | 김순희 | 퍼팅연습기 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55127448A (en) * | 1979-03-23 | 1980-10-02 | Chugai Pharmaceut Co Ltd | Gelatin coating |
| JPS6043046B2 (ja) * | 1979-04-24 | 1985-09-26 | パ−ク・デ−ビス・エンド・コンパニ− | ゼラチンカプセル |
| JPS55161863A (en) * | 1979-06-06 | 1980-12-16 | Paaku Deebisu Kk | Colored gelatin capsule |
| ATE33348T1 (de) * | 1983-11-30 | 1988-04-15 | Siegfried Ag | Coronartherapeutikum in form von weichgelatinekapseln. |
| JPS61225109A (ja) * | 1985-03-29 | 1986-10-06 | Shiseido Co Ltd | カラメル含有組成物 |
| DE3526546A1 (de) * | 1985-07-25 | 1987-01-29 | Scherer Gmbh R P | Lichtbestaendige opakisierte gelatinekapseln und verfahren zur herstellung derselben |
| DE3532129A1 (de) * | 1985-09-10 | 1987-03-12 | Bayer Ag | Ss-carotin enthaltende gelatine |
| US4689233A (en) * | 1986-01-06 | 1987-08-25 | Siegfried Aktiengesellschaft | Coronary therapeutic agent in the form of soft gelatin capsules |
| DE3682208D1 (de) * | 1986-12-18 | 1991-11-28 | Kurt Heinz Bauer | Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung. |
| JPS63215641A (ja) * | 1987-03-05 | 1988-09-08 | Toyo Jozo Co Ltd | ゼラチン皮膜組成物 |
| JPH01218573A (ja) * | 1988-02-25 | 1989-08-31 | Yoshio Tanaka | ドナリエラ藻体含有固形状食品の製造法 |
-
1990
- 1990-07-20 HU HU904564A patent/HUT59592A/hu unknown
-
1991
- 1991-07-10 SE SE9102160A patent/SE9102160L/ not_active Application Discontinuation
- 1991-07-17 CH CH2125/91A patent/CH681960A5/de not_active IP Right Cessation
- 1991-07-17 CZ CS912222A patent/CZ280064B6/cs unknown
- 1991-07-18 KR KR1019910012224A patent/KR920002162A/ko not_active Withdrawn
- 1991-07-19 ZA ZA915677A patent/ZA915677B/xx unknown
- 1991-07-19 FR FR9109183A patent/FR2664814B1/fr not_active Expired - Fee Related
- 1991-07-19 ES ES9101701A patent/ES2039177B1/es not_active Expired - Fee Related
- 1991-07-19 NL NL9101268A patent/NL9101268A/nl not_active Application Discontinuation
- 1991-07-19 JP JP3203542A patent/JPH04253924A/ja active Pending
- 1991-07-19 IT ITMI912002A patent/IT1250681B/it active IP Right Grant
- 1991-07-19 DK DK137591A patent/DK137591A/da not_active Application Discontinuation
- 1991-07-19 TW TW080105605A patent/TW203012B/zh active
- 1991-07-19 YU YU127191A patent/YU47573B/sh unknown
- 1991-07-19 BE BE9100683A patent/BE1006829A3/fr not_active IP Right Cessation
- 1991-07-19 FI FI913493A patent/FI913493L/fi not_active Application Discontinuation
- 1991-07-19 DE DE4124081A patent/DE4124081A1/de not_active Withdrawn
- 1991-07-19 GR GR910100319A patent/GR1002175B/el unknown
- 1991-07-19 IL IL98894A patent/IL98894A0/xx unknown
- 1991-07-19 CA CA002047482A patent/CA2047482A1/en not_active Abandoned
- 1991-07-19 GB GB9115693A patent/GB2246072B/en not_active Expired - Fee Related
-
1996
- 1996-03-08 CY CY184096A patent/CY1840A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2235899T3 (es) | Composicion de micro-emulsion oral de silibin. | |
| ES2096781T3 (es) | Composiciones de oxicodones de liberacion controlada. | |
| ZA836582B (en) | Constant release rate solid oral dosage formulations of drugs having a pka7-10 and an aqueous solubility of 15-100g/ml water | |
| RU2000131897A (ru) | Пероральная дозировочная композиция пролонгированного действия | |
| DK1173153T3 (da) | Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler | |
| NO20020975L (no) | Retardierte administreringsformer inneholdende tramadolsakkarinat | |
| ES2134953T3 (es) | Capsulas de gelatina que contienen una solucion de acetaminofeno altamente concentrada. | |
| ES2035821T3 (es) | Sistema de administracion enterica dirigida. | |
| DE3484779D1 (de) | Pharmazeutische mittel. | |
| KR910000100A (ko) | 라니티딘 함유 제약 조성물 | |
| CA1293929C (en) | Pharmaceutical composition containing nifedipine | |
| NO20014718D0 (no) | Formulering inneholdende testosteron-undekanoat og castorolje | |
| EP0839029A1 (en) | Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules | |
| PE68899A1 (es) | Composicion que contiene paracetamol | |
| AR019053A1 (es) | Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen | |
| NZ270748A (en) | Sustained release dosage form of alfuzosin hydrochloride coated with a ph-dissolution dependent polymer | |
| KR940021054A (ko) | 캡슐형 유비데카레논 경구 제제 | |
| ES2342825T3 (es) | Solucion de ibuprofeno para capsulas de cubierta dura. | |
| KR960703335A (ko) | 캡슐화된 약제(encapsulated medicine) | |
| ES2175663T3 (es) | Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis. | |
| ES2119748T3 (es) | Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua. | |
| LV10267A (lv) | Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai | |
| ES2039177A1 (es) | Proceso de preparacion de compuestos farmaceuticos solidos que contienen un ingrediente activo sensible a la luz | |
| CO4970832A1 (es) | Nuevas formulaciones y procesos para su fabricacion | |
| AU1452402A (en) | Novel pharmaceutical formulation in the form of cellulose capsules suitable for benzimidazole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 20001009 |